Skip to main content

Table 3 Outcomes in patients with or without autoimmune rheumatic disease who experienced a first myocardial infarction between 1 July 2001 and 30 June 2007 a

From: Increased 30-day and 1-year mortality rates and lower coronary revascularisation rates following acute myocardial infarction in patients with autoimmune rheumatic disease

Variable

Non-AIRD (n = 77,981)

AIRD (n = 1,409)

Crude OR (95% CI)

Adjusted OR b (95% CI)

30-day mortality, all cause

10,452 (13.4)

301 (21.4)

1.76 (1.54 to 2.00)

1.44 (1.26 to 1.65)

30-day mortality, cardiovascular

9,105 (11.7)

266 (18.9)

1.76 (1.54 to 2.02)

1.44 (1.25 to 1.66)

12-month mortality, all cause

17,766 (22.8)

544 (38.6)

2.13 (1.91 to 2.38)

1.82 (1.61 to 2.05)

12-month mortality, cardiovascular

15,095 (19.4)

464 (32.9)

2.05 (1.83 to 2.29)

1.71 (1.51 to 1.94)

  1. aAIRD, Autoimmune rheumatic disease; OR, Odds ratio. bAdjusted for age, sex, Accessibility/Remoteness Index of Australia, Socio-Economic Indexes for Areas and comorbidities.